Early blastic transformation with CNS infiltration in a patient with chronic myeloid leukaemia treated with imatinib

Lancet Oncol. 2005 Feb;6(2):128. doi: 10.1016/S1470-2045(05)01744-4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Blast Crisis
  • Blindness / etiology
  • Central Nervous System / pathology*
  • Chromosomes, Human, Pair 10 / genetics
  • Chromosomes, Human, Pair 19 / genetics
  • Chromosomes, Human, Pair 6 / genetics
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemic Infiltration*
  • Male
  • Philadelphia Chromosome
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Retina / pathology
  • Trisomy

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate